POMALIDOMIDE
pomalidomide 3 mg capsule, 14
POMALIDOMIDE (12666P)
12666P
Manner of administration:Oral
Restriction
Indication: Multiple myeloma
Treatment phase: Initial treatment with triple therapy (this drug, bortezomib and dexamethasone)
Restriction
Indication: Multiple myeloma
Treatment phase: Continuing treatment with triple therapy (this drug, bortezomib and dexamethasone)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 14 | # of repeats: 2 | DPMQ: $706.08 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Pomalidomide Sandoz | |||||
| Pomolide | |||||